Working… Menu
Trial record 1 of 2 for:    morphogenesis | melanoma
Previous Study | Return to List | Next Study

pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03655756
Recruitment Status : Active, not recruiting
First Posted : August 31, 2018
Last Update Posted : July 13, 2021
H. Lee Moffitt Cancer Center and Research Institute
Information provided by (Responsible Party):
Morphogenesis, Inc.

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 10, 2020
Estimated Study Completion Date : July 31, 2021
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 August 13, 2021
September 9, 2021
2 October 21, 2021